|Bid||455.15 x 1000|
|Ask||456.60 x 800|
|Day's Range||440.31 - 456.87|
|52 Week Range||440.02 - 549.52|
|Beta (5Y Monthly)||0.86|
|PE Ratio (TTM)||19.27|
|Forward Dividend & Yield||5.92 (1.27%)|
|Ex-Dividend Date||Mar 09, 2023|
|1y Target Est||N/A|
Strong local presence, improving top line, membership hike and significant new contracts in its government business poise Elevance Health (ELV) well for growth.
UnitedHealth, Elevance Health, Humana and Centene are included in this Analyst Blog.
U.S. President Joe Biden's proposal is also likely to enhance Medicare's ability to negotiate prices for drugs.